SPX3,585.62-54.85 -1.51%
DIA287.30-4.91 -1.68%
IXIC10,575.62-161.89 -1.51%

Update: Genfit's Cholangiocarcinoma Therapy Candidate Secures US FDA Orphan Drug Designation -- Shares Rise Pre-Market

Update: Genfit's Cholangiocarcinoma Therapy Candidate Secures US FDA Orphan Drug Designation -- Shares Rise Pre-Market

MT Newswires · 09/14/2022 02:38

Please log in to view news